Tradestie Institutional Equity Comparison Engine

NMAD vs BBLG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NMAD Overall Edge

NMAD Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NMAD (NMAD) driven by superior Momentum & Technical, Options & Structure while BBLG counters with relative strength in Growth & Margin. Fundamentally, NMAD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus BBLG at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NMAD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BBLG sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NMAD N/M vs BBLG N/M Fwd P/E
Growth & Margin Winner BBLG
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner NMAD
1Y -65.1% vs -82.9% ยท 52W Pos 8% vs 0%
Options & Structure Winner NMAD
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
NMAD US Equity
NMAD
Institutional Equity
$2.56
+13.53% 1D
Market Cap N/A
1M Return -28.89%
1Y Return -65.12%
Forward P/E N/M
Unified AI Score
47.9 / 100 HOLD
Tech 43.0 Fund 49.0 Flow 50.0 Mom 70.0
BBLG NASDAQ
Bone Biologics Corp Common Stock
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.27
-2.4% 1D
Market Cap $932,329
1M Return -33.8%
1Y Return -82.9%
Forward P/E N/M
Unified AI Score
44.8 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NMAD -65.12% BBLG -82.9% Spread: +16.23 pp (NMAD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NMAD TTM Op. Margin: N/A BBLG TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMAD vs BBLG. Trailing 12-month operating profitability (NMAD N/A vs BBLG 0.0%) and valuation multiples (NMAD N/M vs BBLG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NMAD (2) vs BBLG (6)
Institutional Metric NMAD BBLG Criterion Row Winner
Market Capitalization Scale N/A $932,329 Larger Scale BBLG
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth BBLG
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin BBLG
Net Profit Margin Profitability N/A 0.0% Higher Margin BBLG
Return on Equity (ROE) Capital Efficiency N/A -47.5% Higher ROE BBLG
52-Week Range Position Momentum 8% ($2โ€“$8) 0% ($0โ€“$2) Stronger Trend NMAD
Beta / 30D Volatility Risk Regime 0.52ฮฒ ยท 173% Vol 0.97ฮฒ ยท 102% Vol Lower Realized Risk BBLG
Unified Institutional Score Composite Signal 47.9 / 100 (HOLD) 44.8 / 100 (HOLD) Higher Composite NMAD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NMAD vs BBLG Buy Guide
NMAD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NMAD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BBLG BREAKDOWN
104d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BBLG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NMAD nor BBLG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.